# Latigo Biotherapeutics, Inc.: filings

LTGO · Nasdaq · CIK 2056611 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ltgo.md) · [Financials](/companies/ltgo/financials.md) · [Filings](/companies/ltgo/filings.md) · [Insiders](/companies/ltgo/insiders.md)

## Reports and events: 7 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 12, 4 6, SCHEDULE 13G 4, 8-K 2, DRS/A 2, S-1/A 2, 10-Q 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, EFFECT 1, S-1 1, S-1MEF 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-03 | 16:32 ET | [10-Q](/filings/0001193125-26-381969.md) | Quarterly report, period 2026-06-30 | 0001193125-26-381969 |
| 2026-09-03 | 16:15 ET | [8-K](/filings/0001193125-26-381912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-381912 |
| 2026-08-17 | 19:06 ET | [SCHEDULE 13D](/filings/0001104659-26-097980.md) | Ownership report, active investor | 0001104659-26-097980 |
| 2026-08-10 | 16:02 ET | [8-K](/filings/0001193125-26-342321.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-342321 |
| 2026-08-04 | 21:54 ET | [S-1/A](/filings/0001193125-26-331205.md) | Registration statement, amended | 0001193125-26-331205 |
| 2026-08-03 | 06:06 ET | [S-1/A](/filings/0001193125-26-329431.md) | Registration statement, amended | 0001193125-26-329431 |
| 2026-07-17 | 12:33 ET | [S-1](/filings/0001193125-26-307306.md) | Registration statement | 0001193125-26-307306 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:05 ET. No prices; not investment advice.